Critical Care Explorations (May 2024)

Can Machine Learning Personalize Cardiovascular Therapy in Sepsis?

  • Finneas J. R. Catling, MSc, MRCP(UK), FFCI,
  • Myura Nagendran, BMBCh, MRCP(UK), FRCA, FFICM,
  • Paul Festor, MEng, MSc,
  • Zuzanna Bien, BMBCh,
  • Steve Harris, PhD, FRCA, FFICM,
  • A. Aldo Faisal, PhD,
  • Anthony C. Gordon, MD, FRCA, FFICM, FMedSci,
  • Matthieu Komorowski, PhD

DOI
https://doi.org/10.1097/CCE.0000000000001087
Journal volume & issue
Vol. 6, no. 5
p. e1087

Abstract

Read online

Large randomized trials in sepsis have generally failed to find effective novel treatments. This is increasingly attributed to patient heterogeneity, including heterogeneous cardiovascular changes in septic shock. We discuss the potential for machine learning systems to personalize cardiovascular resuscitation in sepsis. While the literature is replete with proofs of concept, the technological readiness of current systems is low, with a paucity of clinical trials and proven patient benefit. Systems may be vulnerable to confounding and poor generalization to new patient populations or contemporary patterns of care. Typical electronic health records do not capture rich enough data, at sufficient temporal resolution, to produce systems that make actionable treatment suggestions. To resolve these issues, we recommend a simultaneous focus on technical challenges and removing barriers to translation. This will involve improving data quality, adopting causally grounded models, prioritizing safety assessment and integration into healthcare workflows, conducting randomized clinical trials and aligning with regulatory requirements.